Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.

Lincoff, A M; Califf, R M; Moliterno, D J; Ellis, S G; Ducas, J; Kramer, J H; Kleiman, N S; Cohen, E A; Booth, J E; Sapp, S K; Cabot, C F; Topol, E J

Lincoff, A M; Califf, R M; Moliterno, D J; Ellis, S G; Ducas, J; Kramer, J H; Kleiman, N S; Cohen, E A; Booth, J E; Sapp, S K; Cabot, C F; Topol, E J.

Affiliation

Lincoff AM; Department of Cardiology, Cleveland Clinic Foundation, OH 44195, USA.

N Engl J Med ; 341(5): 319-27, 1999 Jul 29.

Article in En | MEDLINE | ID: mdl-10423466

Subject(s)

Angioplasty, Balloon, Coronary; Antibodies, Monoclonal/therapeutic use; Coronary Disease/therapy; Immunoglobulin Fab Fragments/therapeutic use; Platelet Aggregation Inhibitors/therapeutic use; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors; Stents; Abciximab; Combined Modality Therapy; Coronary Angiography; Coronary Disease/complications; Coronary Disease/drug therapy; Coronary Disease/mortality; Diabetes Complications; Female; Follow-Up Studies; Humans; Incidence; Male; Myocardial Infarction/epidemiology; Recurrence; Single-Blind Method; Ticlopidine/therapeutic use; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Fab Fragments / Platelet Aggregation Inhibitors / Angioplasty, Balloon, Coronary / Stents / Platelet Glycoprotein GPIIb-IIIa Complex / Coronary Disease / Antibodies, Monoclonal Type of study: Clinical_trials / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: N Engl J Med Year: 1999 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links